Overview
Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers
Status:
Completed
Completed
Trial end date:
2008-01-01
2008-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine whether CP-866,087 is effective in the weight loss of overweight patients.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Pfizer
Criteria
Inclusion Criteria:- Body Mass Index (BMI) 30 to 40 kg/m2 and total body weight of >110 lbs.
- Otherwise healthy
Exclusion Criteria:
- Women must be of non-childbearing potential.
- Significant current or history of medical illness.